The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

Wed, 25th Nov 2020 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

JEFFERIES RAISES ANTOFAGASTA TO 'BUY' ('HOLD') - TARGET 1,400 (1,100) PENCE

----------

JEFFERIES RAISES GLENCORE TO 'BUY' ('HOLD') - TARGET 250 (175) PENCE

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 250 (240) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES DIAGEO TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 3,450 (2,750) PENCE

----------

BANK OF AMERICA RAISES DIAGEO PRICE TARGET TO 3,550 (3,300) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS IMPERIAL BRANDS PRICE TARGET TO 1,580 (1,590) PENCE - 'NEUTRAL'

----------

UBS CUTS COMPASS GROUP PRICE TARGET TO 1,400 (1,420) PENCE - 'NEUTRAL'

----------

UBS CUTS B&M TO 'NEUTRAL' ('BUY') - TARGET 505 (425) PENCE

----------

JPMORGAN RAISES MELROSE INDUSTRIES TARGET TO 185 (165) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES NATWEST PRICE TARGET TO 150 (130) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES STANDARD CHARTERED TARGET TO 410 (400) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES LLOYDS PRICE TARGET TO 45 (40) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES BARCLAYS PRICE TARGET TO 145 (130) PENCE - 'EQUAL-WEIGHT'

----------

CREDIT SUISSE RAISES CRH PRICE TARGET TO 43 (41) EUR - 'OUTPERFORM'

----------

JEFFERIES RAISES CRH PRICE TARGET TO 38.70 (38.20) EUR - 'BUY'

----------

JPMORGAN RAISES CRH PRICE TARGET TO 40 (37) EUR - 'OVERWEIGHT'

----------

DZ BANK RAISES FAIR VALUE FOR CRH TO 39.5 (38.5) EUR - 'BUY'

----------

GOLDMAN SACHS CUTS PENNON GROUP PRICE TARGET TO 1,082 (1,149) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS SAGE GROUP PRICE TARGET TO 550 (600) PENCE - 'SELL'

----------

JPMORGAN CUTS SAGE GROUP PRICE TARGET TO 560 (600) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES AUTO TRADER GROUP TARGET TO 420 (348) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES INFORMA PRICE TARGET TO 440 (389) PENCE - 'NEUTRAL'

----------

HSBC RAISES WHITBREAD PRICE TARGET TO 3,900 (3,095) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS INTERTEK PRICE TARGET TO 6,530 (6,630) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

HSBC CUTS GREENCORE TO 'HOLD' ('BUY') - TARGET 120.1 (209.9) PENCE

----------

PEEL HUNT RAISES GENUS PRICE TARGET TO 4,600 (3,470) PENCE - 'HOLD'

----------

LIBERUM RAISES GENUS PRICE TARGET TO 4,490 (4,320) PENCE - 'BUY'

----------

LIBERUM RAISES PETS AT HOME PRICE TARGET TO 420 (350) PENCE - 'HOLD'

----------

BERENBERG RAISES PETS AT HOME PRICE TARGET TO 480 (450) PENCE - 'BUY'

----------

JPMORGAN RAISES BABCOCK INTERNATIONAL TARGET TO 405 (308) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ROTORK PRICE TARGET TO 310 (300) PENCE - 'OVERWEIGHT'

----------

RBC CUTS PETROFAC PRICE TARGET TO 255 (330) PENCE - 'SECTOR PERFORM'

----------

JEFFERIES RAISES KAZ MINERALS PRICE TARGET TO 670 (640) PENCE - 'HOLD'

----------

RBC RAISES BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 360 (350) PENCE - 'OUTPERFORM'

----------

LIBERUM CUTS BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 345 (350) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES ASHMORE GROUP TARGET TO 422 (417) PENCE - 'EQUAL-WEIGHT'

----------

BANK OF AMERICA RAISES INVESTEC PRICE TARGET TO 212 (180) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 430 (470) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN INITIATES CLINIGEN WITH 'NEUTRAL' - TARGET 650 PENCE

----------

LIBERUM RAISES AB DYNAMICS PRICE TARGET TO 2,300 (2,100) PENCE - 'BUY'

----------

JEFFERIES RAISES FORTERRA PRICE TARGET TO 231 (200) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES FORTERRA PRICE TARGET TO 259 (234) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES BANK OF IRELAND TARGET TO 3 (2,20) EUR - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES ALLIED IRISH BANKS TARGET TO 1,45(1,30)EUR 'EQUAL-WEIGHT'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2021 08:16

Clinigen to be taken private by Triton in £1.2bn deal, shares surge

(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.

Read more
2 Dec 2021 14:28

Shares in Clinigen surge on takeover talks with Triton Investment

Shares in Clinigen surge on takeover talks with Triton Investment

Read more
2 Dec 2021 12:59

Clinigen confirms takeover talks with Triton, shares surge

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.

Read more
2 Dec 2021 09:52

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Read more
1 Dec 2021 13:42

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Read more
29 Nov 2021 11:21

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:55

Liberum lowers target price on Clinigen

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".

Read more
8 Oct 2021 08:46

Clinigen and Humanigen partner to progress investigational Covid drug

Clinigen and Humanigen partner to progress investigational Covid drug

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
22 Sep 2021 13:34

Clinigen to distribute 'Copiktra' in most of Europe

(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.

Read more
16 Sep 2021 12:29

Clinigen cuts full-year earnings forecasts, shares fall

(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.

Read more
16 Sep 2021 12:07

Clinigen shares fall on lowered outlook as profit more than doubles

Clinigen shares fall on lowered outlook as profit more than doubles

Read more
16 Sep 2021 10:55

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.